ORIGIO A/S
CVR: 10975077
Secondary names: MEDI-CULT A/S, MEDICULT A/S, ORIGIO SCANLAB EQUIPMENT A/S
The financial health of ORIGIO A/S shows signs of instability, particularly with a notable decline in profitability in 2024, where profit dropped to 13 million DKK from 29 million DKK in 2023, despite revenue remaining relatively stable at 864 million DKK. The company experienced a significant loss in 2022, which raises concerns about its ability to maintain consistent profit margins. Equity has decreased from 429 million DKK in 2021 to 186 million DKK in 2024, indicating potential challenges in financial resilience. Positioned within the research and experimental development sector, ORIGIO A/S must address these financial fluctuations to strengthen its market position and ensure sustainable growth.
AI-generated summary
Overview
Details
Contact
Advertising protectedPurpose
Selskabets formål er at udvikle, producere og sælge produkter til brug inden for området for human reproduktion og cellekulturer og anden dermed forbunden virksomhed efter direktions skøn.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 863.6 mio. | 13 mio. | 445.9 mio. | 186.8 mio. | 111000 | |
History
Ownership
Management
Directors
Founders
Production units (7)
Similar companies
Companies in the same industry and area